✦ LIBER ✦

The role of high-dose cytarabine in induction therapy for adult ALL

✍ Scribed by Nicola Gökbuget; Dieter Hoelzer

Book ID: 108403213
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 41 KB
Volume: 26
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(01)00176-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose, continuous-infusion cyclophos

High-dose, continuous-infusion cyclophosphamide, cytarabine, vincristine, and prednisone for remission induction in refractory adult acute leukemia

✍ Jr. Troy H. Guthrie 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 2 views

A single, high dose of idarubicin combin

A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia

✍ Mark A. Weiss; Timothy B. Aliff; Martin S. Tallman; Stanley R. Frankel; Matt E. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Background: The majority of adult patients who are treated for lymphoblastic disease will either develop recurrent disease or will be refractory to their initial therapy. one option for patients with recurrent/refractory disease is to administer a reinduction regimen that employs a dose-intense

A phase I trial of a single high dose of

A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia

✍ Weiss, M A; Drullinsky, P; Maslak, P; Scheinberg, D; Golde, D W 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

Phase I study of dose dense induction an

Phase I study of dose dense induction and consolidation with gemtuzumab ozogamicin and high dose cytarabine in older adults with AML

✍ Arati V. Rao; David A. Rizzieri; Carlos M. DeCastro; Louis F. Diehl; Anand S. La 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 270 KB

Effects of glycosylated recombinant huma

Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia

✍ Bradstock, K; Matthews, J; Young, G; Lowenthal, R; Baxter, H; Arthur, C; Bashfor 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Phase II evaluation of an intensified in

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)

✍ Stephen H. Petersdorf; Cathryn Rankin; David R. Head; Howard R. Terebelo; Cheryl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views